White labcorp logo

Exciting news: Invitae joins Labcorp to expand the future of genetic testing. Learn more

A powerful tool for cancer

Alvin – Man Looking off in the Distance – Genetic Testing for Cancer Genes
  • A cancer diagnosis is stressful and overwhelming. We’re here to help.

    Understanding your genes can help guide you and your doctor to the most effective treatments, bringing you one step closer to beating cancer and then staying healthy in the long term.

Genetic testing and cancer

Genetic testing and cancer genes

Forty percent of men and thirty-nine percent of women in the US will develop cancer during their lifetimes.¹

In many cases, a person’s genetics has made them more susceptible to cancer. Genetic testing can help identify these pathogenic variants that can help guide care decisions.

How testing works

We know you’re getting a lot of tests right now. Our genetic tests can be started from the comfort of your home with a simple saliva sample.

  • Icon – Mouse Clicking on Screen

    Step 1

    Request a test online via a telehealth clinician or work with your doctor.

  • icon test box

    Step 2

    Provide a saliva sample from the comfort of your home and ship it to our lab.

  • Icon Genetic  Counselor

    Step 3

    Get your results and share them with your doctor. If you'd like, talk to a genetic counselor.

Find the right test

Find the right test

Invitae offers a number of genetic tests focused on specific types of cancer. Each comes with clear next steps, so you and your doctor can make decisions personalized to your genes.

References

1. SEER*Explorer. All Cancer Sites Combined Recent Trends in SEER Age-Adjusted Incidence Rates, 2000-2019. National Cancer Institute. Accessed November 22, 2022. https://seer.cancer.gov/statistics-network/explorer
2. Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. Published online October 30, 2020. doi:10.1001/jamaoncol.2020.6252
3. Ji Y, et al. J Mol Diagn. 2016 May; 18(3): 438-445